|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/48 | |
| A61P 19/10 |
| (11) | Patento numeris | 2480250 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10761093.3 |
| Europos patento paraiškos padavimo data | 2010-09-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-08-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-04-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/049844 |
| Data | 2010-09-22 |
| (87) | Numeris | WO 2011/038015 |
| Data | 2011-03-31 |
| (30) | Numeris | Data | Šalis |
| 245595 P | 2009-09-24 | US |
| (72) |
RIMANDO, Marlon P., US
|
| (73) |
Allergan, Inc.,
2525 Dupont Drive, T2-7H, Irvine, CA 92612,
US
|
| (54) | Compositions comprising botulinum toxin A or B for use in the treatment of osteoporosis |
| Compositions comprising botulinum toxin A or B for use in the treatment of osteoporosis |